Global Custom Market Research Reports Provider Company

phone

OSE Immunotherapeutics (OSE) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: France
Summary

OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The companys memopi technology is employed in studying the development of treatments for ovarian, colon and breast cancer. Its products include tedopi and effi-7. OSEs Effi-7 is in preclinical development and targets autoimmune diseases and transplantation. The companys tedopi stimulates cytotoxic killer T cells and relearns them to detect cancer cells to eliminate them. It markets its products through its distribution network. OSE is headquartered in Nantes, France.

OSE Immunotherapeutics Key Recent Developments

Sep 07,2017: OSE Immunotherapeutics Reports on First-Half 2017 Financial Results and Provides Update on Clinical Advances of Its Product Portfolio
May 18,2017: OSE Immunotherapeutics to Present at Annual Sachs Immuno-Oncology: BD&L and Investment Forum
Nov 28,2016: OSE Immunotherapeutics Appoints Dr. Frederique Corallo as Chief Medical Officer, Immunology
Nov 16,2016: Selexis, OSE partner to advance immunotherapies development for cancer diseases
Sep 15,2016: OSE Immunotherapeutics reinforces its Clinical Team with the Appointment of Iris Pauporte as Clinical Project Director

This comprehensive SWOT profile of OSE Immunotherapeutics provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OSE Immunotherapeutics including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



OSE Immunotherapeutics - Key Information

OSE Immunotherapeutics - Overview

OSE Immunotherapeutics - Key Employees

OSE Immunotherapeutics - Key Employee Biographies

OSE Immunotherapeutics - Key Operational Heads

OSE Immunotherapeutics - Major Products and Services

OSE Immunotherapeutics - History

OSE Immunotherapeutics - Company Statement

OSE Immunotherapeutics - Locations And Subsidiaries

OSE Immunotherapeutics - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



OSE Immunotherapeutics - Business Description

OSE Immunotherapeutics - Corporate Strategy

OSE Immunotherapeutics - SWOT Analysis

SWOT Analysis - Overview

OSE Immunotherapeutics - Strengths

OSE Immunotherapeutics - Weaknesses

OSE Immunotherapeutics - Opportunities

OSE Immunotherapeutics - Threats

OSE Immunotherapeutics - Key Competitors



Section 3 - Company Financial Performance Charts



OSE Immunotherapeutics - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




OSE Immunotherapeutics, Key Information

OSE Immunotherapeutics, Key Ratios

OSE Immunotherapeutics, Share Data

OSE Immunotherapeutics, Major Products and Services

OSE Immunotherapeutics, History

OSE Immunotherapeutics, Key Employees

OSE Immunotherapeutics, Key Employee Biographies

OSE Immunotherapeutics, Key Operational Heads

OSE Immunotherapeutics, Other Locations

OSE Immunotherapeutics, Subsidiaries

OSE Immunotherapeutics, Key Manufacturing facilities

OSE Immunotherapeutics, Key Competitors

OSE Immunotherapeutics, SWOT Analysis

OSE Immunotherapeutics, Ratios based on current share price

OSE Immunotherapeutics, Annual Ratios

OSE Immunotherapeutics, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




OSE Immunotherapeutics, Performance Chart

OSE Immunotherapeutics, Ratio Charts

Paragon Bioservices Inc (Paragon Bioservices) is a contract development and manufacturing organization that provides contract research, development and GMP manufacturing services. The organizations research services include recombinant protein expression and

View Report

Sosei Group Corp (Sosei) is a biopharmaceutical company that develops and commercializes drugs. The companys products comprise NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive

View Report

Orthosera GmbH (OrthoSera), formerly Lacerta Technologies GmbH is a regenerative medicine company that research and develops serum-based orthobiologics. The company provides bone grafts technology, which is used in treatment of

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports